top of page
CorEx

CorEx

Reveal, Assure, Decide

CorEx is a comprehensive CCTA analysis tool, a deep-learning point-of-care solution that automatically identifies and classifies coronary lesions based on CCTA scans. CorEx also calculates lesion related FFR value, enabling optimal patient management, in less than one minute.

CCTA is recommended by the ESC and the AHA as the first line test for patients with stable chest pain with the strongest level of evidence.

Ischemia assessment (FFR ≤ 0.8 threshold) is required to make a revascularization decision.

An AI prediction from a CT scan can be useful for the diagnosis of vessel specific ischemia and may avoid this invasive examination, that, in a majority of cases, leads to unnecessary downstream angioplasty procedures.

Spimed-KV-OK.jpg

CAD RADS

CorEx automatically classifies lesions (stenoses) according to the international CAD-RADS classification, helping to choose optimal treatment for the patient

FFR AI

Corex provide an estimation of the Fractional Flow Reserve (FFR) in less than a minute. This analysis doesn’t require any core lab intervention.

The measurement of FFR is used to determine the need for revascularization by stent or bypass.

This analysis helps to reduce diagnostic ICA numbers by
increasing cardiologists and radiologists confidence in their diagnostic.

Benefits
10 validation studies
Less than a minute of turnaround time
16 Countries
On premise or Cloud
2 patents validated
Plan de travail 1.png
Very satisfied, CorEx is progressively changing my practice: this deep learning software brings a valuable help for evaluating coronary artery stenosis.

Dr Hervé BLACHERE, Radiologist

Technology

Spimed-AI leverages powerful artificial intelligence models trained on over 10,000 expertly annotated medical scans.

Our technology enables highly accurate detection of coronary lesions and advanced 3D vessel modeling.

Unlike traditional methods such as Computational Fluid Dynamics (CFD), our technology delivers
near-instant results without compromising precision. It streamlines image interpretation, shortens diagnostic timelines, and enhances clinical decisions.

Backed by two patents, the solution is GDPR-compliant, clinically validated, and is
already CE certified under the MDD regulation.

Technology.jpg
Technology

Download
our flyer

mockupFlyer.png
bottom of page